Literature DB >> 25425283

Complex lipid trafficking in Niemann-Pick disease type C.

Marie T Vanier1.   

Abstract

Niemann-Pick disease type C (NPC) is an atypical lysosomal storage disease resulting from mutations in one of two genes, either NPC1 or NPC2. Although a neurovisceral disorder, it is above all a neurodegenerative disease in the vast majority of patients. Not an enzyme deficiency, it is currently conceived as a lipid trafficking disorder. Impaired egress of cholesterol from the late endosomal/lysosomal (LE/L) compartment is a specific and key element of the pathogenesis, but other lipids, more specially sphingolipids, are also involved, and there are indications for further abnormalities. The full function of the NPC1 and NPC2 proteins is still unclear. This review provides a reappraisal of lipid storage and lysosomal enzymes activities in tissues/cells from NPC patients and animal models. It summarizes the current knowledge on the NPC1 and NPC2 proteins and their function in transport of cholesterol within the late endosomal-lysosomal compartment, with emphasis on differences between systemic organs and the brain; it also discusses regulation by membrane lipids of the NPC2-mediated cholesterol trafficking, interplay between cholesterol and sphingomyelin, the metabolic origin of glycosphingolipids stored in brain, and the putative role of free sphingoid bases in pathogenesis. Brief mention is finally made of diseases affecting other genes that were very recently shown to impact the "NPC pathway".

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25425283     DOI: 10.1007/s10545-014-9794-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  92 in total

1.  Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases.

Authors:  V Puri; R Watanabe; M Dominguez; X Sun; C L Wheatley; D L Marks; R E Pagano
Journal:  Nat Cell Biol       Date:  1999-10       Impact factor: 28.824

Review 2.  Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature.

Authors:  M T Vanier
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

3.  Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing.

Authors:  M T Vanier; C Rodriguez-Lafrasse; R Rousson; N Gazzah; M C Juge; P G Pentchev; A Revol; P Louisot
Journal:  Biochim Biophys Acta       Date:  1991-06-05

Review 4.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

5.  Elevated endosomal cholesterol levels in Niemann-Pick cells inhibit rab4 and perturb membrane recycling.

Authors:  Amit Choudhury; Deepak K Sharma; David L Marks; Richard E Pagano
Journal:  Mol Biol Cell       Date:  2004-08-03       Impact factor: 4.138

6.  Type C Niemann-Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts.

Authors:  H S Kruth; M E Comly; J D Butler; M T Vanier; J K Fink; D A Wenger; S Patel; P G Pentchev
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

7.  Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease.

Authors:  Na Lin; Huiwen Zhang; Wenjuan Qiu; Jun Ye; Lianshu Han; Yu Wang; Xuefan Gu
Journal:  J Lipid Res       Date:  2013-11-04       Impact factor: 5.922

8.  Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding.

Authors:  Mark E Gelsthorpe; Nikola Baumann; Elizabeth Millard; Sarah E Gale; S Joshua Langmade; Jean E Schaffer; Daniel S Ory
Journal:  J Biol Chem       Date:  2008-01-23       Impact factor: 5.157

Review 9.  Secondary lipid accumulation in lysosomal disease.

Authors:  Steven U Walkley; Marie T Vanier
Journal:  Biochim Biophys Acta       Date:  2008-12-09

10.  Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression.

Authors:  Cristin D Davidson; Nafeeza F Ali; Matthew C Micsenyi; Gloria Stephney; Sophie Renault; Kostantin Dobrenis; Daniel S Ory; Marie T Vanier; Steven U Walkley
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

View more
  87 in total

1.  Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.

Authors:  Kanagaraj Subramanian; Darren M Hutt; Samantha M Scott; Vijay Gupta; Shu Mao; William E Balch
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

2.  Changes in global gene expression indicate disordered autophagy, apoptosis and inflammatory processes and downregulation of cytoskeletal signalling and neuronal development in patients with Niemann-Pick C disease.

Authors:  Katarzyna Hetmańczyk-Sawicka; Roksana Iwanicka-Nowicka; Anna Fogtman; Jarosław Cieśla; Paweł Włodarski; Barbara Żyżyńska-Granica; Mirella Filocamo; Andrea Dardis; Paolo Peruzzo; Małgorzata Bednarska-Makaruk; Marta Koblowska; Agnieszka Ługowska
Journal:  Neurogenetics       Date:  2020-01-11       Impact factor: 2.660

3.  Prospective Turkish Cohort Study to Investigate the Frequency of Niemann-Pick Disease Type C Mutations in Consanguineous Families with at Least One Homozygous Family Member.

Authors:  Meral Topçu; Dilek Aktas; Merih Öztoprak; Neslihan Önenli Mungan; Aysel Yuce; Mehmet Alikasifoglu
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

4.  A Drosophila Genome-Wide Screen Identifies Regulators of Steroid Hormone Production and Developmental Timing.

Authors:  E Thomas Danielsen; Morten E Moeller; Naoki Yamanaka; Qiuxiang Ou; Janne M Laursen; Caecilie Soenderholm; Ran Zhuo; Brian Phelps; Kevin Tang; Jie Zeng; Shu Kondo; Christian H Nielsen; Eva B Harvald; Nils J Faergeman; Macy J Haley; Kyle A O'Connor; Kirst King-Jones; Michael B O'Connor; Kim F Rewitz
Journal:  Dev Cell       Date:  2016-06-20       Impact factor: 12.270

5.  APP overexpression in the absence of NPC1 exacerbates metabolism of amyloidogenic proteins of Alzheimer's disease.

Authors:  Mahua Maulik; Kyle Peake; JiYun Chung; Yanlin Wang; Jean E Vance; Satyabrata Kar
Journal:  Hum Mol Genet       Date:  2015-10-03       Impact factor: 6.150

6.  Systemic AAV9 gene therapy improves the lifespan of mice with Niemann-Pick disease, type C1.

Authors:  Randy J Chandler; Ian M Williams; Alana L Gibson; Cristin D Davidson; Arturo A Incao; Brandon T Hubbard; Forbes D Porter; William J Pavan; Charles P Venditti
Journal:  Hum Mol Genet       Date:  2017-01-01       Impact factor: 6.150

7.  Quantitative Analysis of the Proteome Response to the Histone Deacetylase Inhibitor (HDACi) Vorinostat in Niemann-Pick Type C1 disease.

Authors:  Kanagaraj Subramanian; Navin Rauniyar; Mathieu Lavalleé-Adam; John R Yates; William E Balch
Journal:  Mol Cell Proteomics       Date:  2017-08-31       Impact factor: 5.911

Review 8.  Contribution of tandem mass spectrometry to the diagnosis of lysosomal storage disorders.

Authors:  Monique Piraud; Magali Pettazzoni; Pamela Lavoie; Séverine Ruet; Cécile Pagan; David Cheillan; Philippe Latour; Christine Vianey-Saban; Christiane Auray-Blais; Roseline Froissart
Journal:  J Inherit Metab Dis       Date:  2018-03-19       Impact factor: 4.982

Review 9.  Diagnostic workup and management of patients with suspected Niemann-Pick type C disease.

Authors:  Apostolos Papandreou; Paul Gissen
Journal:  Ther Adv Neurol Disord       Date:  2016-03-02       Impact factor: 6.570

10.  Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism.

Authors:  Sara Boenzi; Federica Deodato; Roberta Taurisano; Bianca Maria Goffredo; Cristiano Rizzo; Carlo Dionisi-Vici
Journal:  J Lipid Res       Date:  2016-01-05       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.